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1. Introduction: 
Carbohydrate mismanagement leads to chronic disorders such as obesity and type 2 diabetes. 
Sedentary lifestyles and high caloric diet intake have been noted as causes for increase in 
carbohydrate mismanagement disorders. Therapeutic drug development against these 
disorders relies on understanding the mechanism of carbohydrate metabolism. Carbohydrates 
forms one of major nutrients in diet and are a major source of energy for mammals. They are 
hydrolysed during digestion to monosaccharides by enzymes in the gastrointestinal tract. 
Monosaccharides cannot infuse the selectively permeable plasma membrane surface of 
intestinal epithelial cells (enterocytes). This entry is mediated by transporters present on the 
apical surface of the enterocytes. Later the monosaccharides exit into the blood stream via the 
transporters located in the enterocyte baso-lateral surface (Hediger, Coady et al. 1987, Wood 
and Trayhurn 2003). The sodium dependent glucose co-transporter (SGLT) of solute carrier 
family 5A (SLC5A) (Wright, Loo et al. 1994, Wright, Loo et al. 2004, Krimi, Letteron et al. 
2009, Wong, Debnam et al. 2009) and the facilitative glucose transporter (GLUT) of the 
solute carrier family 2 (SLC2) family (Uldry and Thorens 2004) are involved in the 
absorption of glucose and some structurally related substances in the small intestine. These 
transporters are also involved in reabsorption of glucose from the glomerular filtrate, uptake 
of glucose across the blood-brain barrier, and in uptake and release of glucose from all cells 
in the body. 
1.1 Sodium Dependent Glucose Co-transporter 1 (SGLT1): 
SGLT1 is identified as a high affinity low capacity transporter (Hediger, Coady et al. 1987, 
Corpe and Burant 1996, Tavakkolizadeh, Berger et al. 2001, Wright, Martin et al. 2003, 
Houghton, Zarroug et al. 2006). Various organs (intestine, trachea, kidneys, heart, brain, 
testis and prostate glands) in humans and rats contain SGLT1 at distinct locations (Balen, 
Ljubojevic et al. 2008, Wright, Loo et al. 2011). The importance of SGLT1 in intestinal 
glucose transport was recognised when it was observed that the absence of functional SGLT1 
in human intestine led to glucose-galactose mal-absorption (Shirazi-Beechey, Gribble et al. 
1994, Wright 1998). SGLT1 is most strongly expressed in the apical membrane of 
enterocytes where it mediates the first step in small intestinal glucose absorption (Hediger, 
Coady et al. 1987, Kellett and Brot-Laroche 2005, Gorboulev, Schurmann et al. 2012). 
SGLT1 mediates glucose transport by symport of sodium ions and glucose with a 
stoichiometric ratio of 2:1. This symport occurs via a secondary active transport where the 
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sodium gradient is generated by the Na
+
/K
+
 ATPase (Figure 1) (Wright, Loo et al. 1994, 
Wright, Martin et al. 2003, Wright, Hirayama et al. 2007).  
 
Figure 1: Model for intestinal secondary active glucose (and galactose) transport across 
the small intestine: The sketch depicts the mechanism of glucose transport occurring within 
a mature enterocyte at the upper villus of the small intestine. Glucose (or galactose) is co-
transported with Na
+
 across the brush border membrane by SGLT1. Glucose then exists 
across the basolateral membrane by GLUT2 or by exocytosis. Na
+
 is actively transported 
across the basolateral membrane by Na
+
/K
+
 ATPase. The energy provided by Na
+
 gradient is 
used for the transport of glucose.  This figure is based on a scheme provided by Wright et al., 
2004. 
1.1.1 Regulation of SGLT1:  
The functional capacity of SGLT1 is regulated to meet up with physiological demands of the 
species (Ferraris 2001).  
Depending on the mechanism, the regulation of SGLT1 can be classified into post-
transcriptional short term regulation and transcriptional and post-transcriptional long term 
regulation (Karasov and Debnam 1987, Wright, Hirsch et al. 1997). 
Post-transcriptional short term regulation occurs in the brush border membrane of enterocytes 
layered with an intact mucosa layer (Sharp, Debnam et al. 1996). This regulation enables 
adaptation to rapid changes of luminal glucose concentration (Wright, Hirsch et al. 1997, 
Kellett and Brot-Laroche 2005). They include modifications of SGLT1 that may alter either 
the affinity, turn over number, vesicular trafficking or degradation bringing change in the 
number of transporter molecules within the plasma membrane (Hirsch, Loo et al. 1996, 
Vayro and Silverman 1999).  
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Several factors mediate the short term post-transcriptional regulation of SGLT1. Protein RS1 
identifies SGLT1 as a physiological target for regulation (Osswald, Baumgarten et al. 2005). 
It mediates post-transcriptional short term regulation of SGLT1 by modulating the 
recruitment of vesicles containing SGLT1 from the intracellular pool at Trans Golgi network 
(TGN) to enterocyte apical surface (Veyhl, Keller et al. 2006). This regulation is dependent 
on intracellular glucose concentration and Protein kinase C (PKC) activation (Veyhl, Wagner 
et al. 2003). Peptides such as Proadrenomedullin N-terminal 20 peptide (PAMP) and 
adrenomedullin (AM) can also post-transcriptionally modulate the exocytosis of intracellular 
vesicles containing SGLT1 for short term regulation. This regulation is suggested to depend 
on cyclic adenosine monophosphate (cAMP) - Protein kinase A (PKA) pathway (Fernandez 
de Arcaya, Lostao et al. 2005). Hormones which can mediate short term regulation of SGLT1 
include glucagon like peptide-2 (GLP-2) (Shirazi-Beechey, Moran et al. 2011), epinephrine 
(Ishikawa, Eguchi et al. 1997), portal insulin (Stumpel, Kucera et al. 1996), glucagon-37 
(Stumpel, Scholtka et al. 1997), leptin (Ducroc, Guilmeau et al. 2005), cholecystokinin 
(CCK) (Hirsh and Cheeseman 1998) and prostaglandin E (PGE2) (Scholtka, Stumpel et al. 
1999). These hormones and peptides may involve activation of secondary messengers such as 
G-protein (α-gustiducin) (Margolskee, Dyer et al. 2007) and cAMP (Ishikawa, Eguchi et al. 
1997, Luz Sdos, de Campos et al. 1997, Stumpel, Scholtka et al. 1997, Lee, Loflin et al. 
2000, Fernandez de Arcaya, Lostao et al. 2005, Shirazi-Beechey, Moran et al. 2011). Protein 
kinases such as PKC (Hirsch, Loo et al. 1996, Wright, Hirsch et al. 1997, Vayro and 
Silverman 1999, Veyhl, Wagner et al. 2003, Barrenetxe, Sainz et al. 2004, Kim, Lee et al. 
2004, Castaneda-Sceppa, Subramanian et al. 2010), PKA (Ishikawa, Eguchi et al. 1997, 
Fernandez de Arcaya, Lostao et al. 2005, Subramanian, Glitz et al. 2009), Serum and 
glucocorticoid inducible kinase-1 (SGK-1) (Shojaiefard, Strutz-Seebohm et al. 2007) and 
glycogen synthase kinase 3 beta (GSK-3β) (Rexhepaj, Dermaku-Sopjani et al. 2010) can be 
involved in post-transcriptional regulation of SGLT1.  
Transcriptional long term regulation of SGLT1 occurs in the cells present in lower villus and 
crypts which later migrate to upper villus and manifest the regulated SGLT1 function 
(Ferraris, Villenas et al. 1992). Although long term regulation of SGLT1 mainly involves 
transcriptional mechanism, it can also be regulated by post-transcriptional mechanism. Long 
term regulation enables adaptation to different diet conditions (Shirazi-Beechey, Hirayama et 
al. 1991), ontogenetic development (Shirazi-Beechey, Smith et al. 1991) differentiation of 
enterocyte for maturation (Freeman, Heavens et al. 1992) and also involves changes during 
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chronic metabolic disorders like diabetes (Fedorak, Gershon et al. 1989, Dyer, Garner et al. 
1997, Dyer, Wood et al. 2002), hypo- or hyperinulinaemia (Philpott, Butzner et al. 1992), 
carcinoma (Alesutan, Sopjani et al. 2012, Hanabata, Nakajima et al. 2012, Lai, Xiao et al. 
2012), obesity (Krimi, Letteron et al. 2009, Sopjani, Bhavsar et al. 2010) and inflammatory 
bowel diseases (Thomson and Wild 1997, Thomson and Wild 1997). These regulations of 
SGLT1 also control its diurnal rhythmic expression depending on the feeding pattern of the 
species (Furuya and Yugari 1974, Fisher and Gardner 1976, Corpe and Burant 1996, Rhoads, 
Rosenbaum et al. 1998, Tavakkolizadeh, Berger et al. 2001, Pan, Terada et al. 2004, 
Houghton, Zarroug et al. 2006). The long term SGLT1 regulation involves modulations in 
mRNA level or change in membrane integrity. Modulation in mRNA level could include 
changes in promoter activity (Dyer, Vayro et al. 2003), mRNA expression (Miyamoto, Hase 
et al. 1993) or mRNA stability (Loflin and Lever 2001, Pedder, Ford et al. 2008). 
Modulations at membrane integrity could include changes in height of microvilli (Smith, 
Peacock et al. 1991), membrane physio-chemical composition (Schwarz, Hostetler et al. 
1985, Schwarz, Bostwick et al. 1989, Vazquez, Rovira et al. 1997), membrane actin 
polymerization (Chung, Wong et al. 1999) or change in the fraction of transporting to non-
transporting cells (Fedorak, Gershon et al. 1989). These modulations at mRNA level and 
membrane integrity may lead to changes in density of transporter molecules (Ferraris and 
Diamond 1992, Ferraris and Diamond 1993), change in surface area for absorption (Smith, 
Peacock et al. 1991), change in rate of transport (Diamond, Karasov et al. 1984), change in 
the cells intended for transporter activity (Fedorak, Gershon et al. 1989) or increase 
translocation of other transporters to apical membrane surface (Krimi, Letteron et al. 2009, 
Sopjani, Bhavsar et al. 2010).   
Prevalence of diet dependent SGLT1 regulation has been observed with changes in sodium 
(Donowitz, De La Horra et al. 1998), fibre (Reimer, Field et al. 1997) and carbohydrate 
content. High consumption of carbohydrate in diet leads to increase in rate of intestinal 
glucose transport by changing SGLT1 mRNA and protein abundance (Shirazi-Beechey, 
Gribble et al. 1994, Dyer, Hosie et al. 1997, Ferraris 2001). Carbohydrate based SGLT1 diet 
regulation is reported among vertebrates like mammals (rats, mice, cows, sheep and humans), 
amphibians (tadpoles) and fishes (tilapia and catfish) but not in birds (Ferraris 2001). Several 
factors are involved in the diet dependent regulation of SGLT1. Protein RS1 regulates 
SGLT1 transcriptionally for adaptation to diet having reduced glucose-galactose content 
(Filatova, Leyerer et al. 2009). High nutrient diet shows transcriptional upregulation of 
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SGLT1 activity by elevation of cAMP levels. Elevated levels of cAMP lead to PKA 
dependent increase in SGLT1 promoter activity (Dyer, Vayro et al. 2003).  
Regulation of SGLT1 with regards to animal development depends on the gestation period, 
age and feeding (Ferraris 2001). These regulations include maintenance of high intestinal 
SGLT1 activity in foetal and neonatal stage (Buddington and Diamond 1989, Vazquez, 
Rovira et al. 1997, Buddington, Malo et al. 2000), gradual decrease in SGLT1 mRNA levels 
from duodenum to ileum of adults (Kojima, Nishimura et al. 1999, Yoshikawa, Inoue et al. 
2011), accumulation of SGLT1 mRNA and insertion of SGLT1 transporters at the apical 
membrane during enterocyte maturation (Delezay, Baghdiguian et al. 1995), maintenance of 
SGLT1 diurnal rhythm (Rhoads, Rosenbaum et al. 1998, Martin, Wang et al. 2000, Vayro, 
Wood et al. 2001, Balakrishnan, Stearns et al. 2008, Kekuda, Saha et al. 2008) and abnormal 
SGLT1 activity during chronic occurrence of various metabolic disorders (Fedorak, Gershon 
et al. 1989). Several factors are involved for regulation of SGLT1 for animal development 
and cellular differentiation. Protein RS1 mediates transcriptional regulation of SGLT1 in 
LLCPK1 cells (porcine kidney epithelial cell line) dependent on cell confluence (Korn, 
Kuhlkamp et al. 2001, Filatova, Leyerer et al. 2009). Other proteins like a 38kDa nucleo-
cytoplasmic protein (Lee, Loflin et al. 2000) and a RNA binding protein (HuR) (Loflin and 
Lever 2001) are involved in SGLT1 regulation during cell differentiation. Some factors 
which are involved in regulation of SGLT1 during chronic disorders or diseases such as 
carcinoma, diabetes, obesity, short bowel syndrome and intestinal inflammation include 
protein complexes like Nuclear factor kappa-light-chain-enhancer of activated B cells 
(NFκB) (Lee, Heo et al. 2007), hormones like angiotensin II (Wong, Debnam et al. 2009) and 
resistin like molecule β (RELMβ) (Krimi, Letteron et al. 2009, Sopjani, Bhavsar et al. 2010), 
growth factors like epidermal growth factor (EGF) (Chung, Wong et al. 1999) protein kinases 
like 5' Adenosine Mono-phosphate activated protein kinase (AMPK) (Krimi, Letteron et al. 
2009, Sopjani, Bhavsar et al. 2010) and Tau tubulin kinase 2 (TTBK2) (Alesutan, Sopjani et 
al. 2012) and transcriptional factors like hepatocyte nuclear factors 1 (HNF1) and specificity 
protein 1 (Sp1) (Rhoads, Rosenbaum et al. 1998, Martin, Wang et al. 2000, Vayro, Wood et 
al. 2001, Balakrishnan, Stearns et al. 2008, Kekuda, Saha et al. 2008). Vagus nerve 
contributes in diurnal rhythm regulation of SGLT1 (Stearns, Balakrishnan et al. 2008, 
Stearns, Balakrishnan et al. 2012). Few of the different secondary messengers and protein 
kinases involved in the long term regulation of SGLT1 include cAMP (Peng and Lever 1995, 
Loflin and Lever 2001), PKA (Dyer, Vayro et al. 2003) and PKC (Castaneda-Sceppa, 
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Subramanian et al. 2010). PKC is involved in transcriptional regulation of SGLT1 by 
involving several intracellular signalling pathways such as p38/MAPK (Mitogen activated 
protein kinase), Extracellular signal regulated kinase (ERK)/MAPK, c-Jun N-terminal kinase 
(JNK)/MAPK and Phosphatidylinositide 3-kinases (PI3K)/Protein kinase B (Akt)/ 
mammalian target of rapamycin (mTOR) (Castaneda-Sceppa, Subramanian et al. 2010).  
1.1.1.1 The RS1 protein and its regulation on SGLT1: 
The Mammalian specific, intronless single copy gene RSC1A1 encodes a 67- 68 KDa protein 
named RS1. Depending on the mammalian species, RSC1A1 gene expression shows a wide 
tissue distribution. RS1 is expressed in kidneys, small intestine, liver, spleen, brain and lungs 
(Veyhl, Spangenberg et al. 1993, Lambotte, Veyhl et al. 1996, Poppe, Karbach et al. 1997, 
Reinhardt, Veyhl et al. 1999, Osswald, Baumgarten et al. 2005). Within the cell RS1 protein 
is distributed below the apical plasma membrane, around the Trans Golgi network (TGN) and 
within the cell nucleus (Valentin, Kuhlkamp et al. 2000, Osswald, Baumgarten et al. 2005, 
Kroiss, Leyerer et al. 2006).  
RS1 regulates the activity of different transporters from different families such as SGLT1 
(Veyhl, Spangenberg et al. 1993), SGLT1 homologous Na
+
 myo-inositol co-transporter 
(SMIT) (Lambotte, Veyhl et al. 1996), organic cation transporters (OCT1 and 2) and 
concentrative nucleoside transporters (CNT1, 2 and 3) (Reinhardt, Veyhl et al. 1999, Veyhl, 
Wagner et al. 2003, Errasti-Murugarren, Fernandez-Calotti et al. 2012). Regulation of SGLT1 
has been studied extensively due to its physiological importance. The deletion of RSC1A1 
gene in mice (RS1-/-) lead to increase in SGLT1 activity. Hence SGLT1 is identified as a 
physiologically important target for RS1 (Osswald, Baumgarten et al. 2005).   
RS1 is involved the transcriptional and post-transcriptional regulation of SGLT1 (Korn, 
Kuhlkamp et al. 2001, Veyhl, Keller et al. 2006). The transcriptional regulation of SGLT1 by 
RS1 was studied in the porcine kidney epithelial cell line - LLCPK1. In LLCPK1 a 
confluence dependent inverse relationship occurs between the nuclear distribution of RS1 and 
the expression of SGLT1. When RS1 expression is down-regulated by antisense strategy or 
overexpressed artificially it resulted in opposite effects on SGLT1 mRNA expression and 
activity. RS1 thereby reveals a transcriptional regulation dependent on cell confluence (Korn, 
Kuhlkamp et al. 2001). In mice fed with glucose-galactose reduced diet (GGRD) RS1 
transcriptionally regulates SGLT1 to mediate higher SGLT1 mRNA and protein expression 
in wild type mice as compared to RS1-/- mice (Filatova, Leyerer et al. 2009). The post-
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transcriptional regulation by RS1 was studied in Xenopus laevis oocytes system where co-
expression of human RS1 (hRS1) and human SGLT1 (hSGLT1) cRNA decreased SGLT1 
activity (Veyhl, Spangenberg et al. 1993, Lambotte, Veyhl et al. 1996, Veyhl, Wagner et al. 
2003). Down regulation of SGLT1 activity also occurred on injecting hRS1 protein in 
hSGLT1 expressing Xenopus laevis oocytes (Veyhl, Keller et al. 2006). This indicated RS1 
as a post-transcriptional regulator of SGLT1. This regulation occurs by inhibiting dynamin 
dependent exocytotic release of hSGLT1 containing vesicles from TGN (Veyhl, Wagner et 
al. 2003, Kroiss, Leyerer et al. 2006, Veyhl, Keller et al. 2006).The regulation is enhanced by 
PKC activation and is dependent on intracellular glucose concentration (Veyhl, Wagner et al. 
2003, Veyhl, Keller et al. 2006).  
Functional characterization of RS1 protein identified an N-terminal domain (TGN-Reg) 
consisting of about 90 residues from 16-98 and 15-92 in human and mouse RS1 (hRS1 and 
mRS1) respectively responsible for post-transcriptional regulation of SGLT1. Two peptide 
sequences - Gln-Ser-Pro (QSP) (Vernaleken, Veyhl et al. 2007) and Ser-Asp-Ser-Asp-Arg-
Ile-Glu-Pro (SDSDRIEP) (M. Vehyl-Wichmann, et al data unpublished) in the TGN-Reg are 
identified capable to mediate this regulation of SGLT1. This domain also comprises of a 21 
residue long nuclear shuttling domain (RNS) to mediate the cell confluence dependent 
nuclear localization of RS1 protein and another domain for controlling the transcriptional 
regulation of SGLT1 (Filatova, Leyerer et al. 2009). The C-terminal sequence of RS1 
contains a tripeptide Gln-Cys-Pro (QCP) which can also mediate post-transcriptional 
regulation of hSGLT1 (Vernaleken, Veyhl et al. 2007) and an ubiquitin associated domain 
(UBA) which has not been characterized (Valentin, Kuhlkamp et al. 2000). QCP and QSP are 
also substrates of H-peptide co-transporter PepT1 and are effectively absorbed when applied 
in the intestine lumen (Vernaleken, Veyhl et al. 2007).  The TGN-Reg domain also consists 
of several consensus sequences for phosphorylation by a variety of protein kinases. The 
putative phosphorylation sites in this domain of hRS1 and mRS1 were screened and their 
comparative alignment is depicted in Figure 2. 
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Figure 2: Comparative alignment between TGN-Reg Domains of hRS1 with mRS1: 
Both hRS1 and mRS1 have several serine and threonine putative phosphorylation sites. The 
sites common in both have been marked in blue. Two QSP motifs are present in hRS1 
whereas only one QSP motif is present in mRS1. SDSDRIEP motif is specifically present 
only in hRS1 sequence. SDSDRIEP is a putative site for PKC α phosphorylation while QSP 
is a putative site for CamK2 phosphorylation. 
1.1.1.2 PKC dependent regulation of SGLT1: 
Several factors mediate the regulation of SGLT1 by involving activation of secondary 
messengers and protein kinases. Involvement of PKC in the regulation of SGLT1 is shown 
during sepsis caused by bacterial lipopolysaccharide (LPS) (Amador, Garcia-Herrera et al. 
2007), during hormonal stimulus like epinephrine (Kim, Lee et al. 2004), Angiotensin II 
(Han, Park et al. 2004), leptin (Ducroc, Guilmeau et al. 2005) and in RS1 protein dependent 
post-transcriptional regulation of SGLT1 (Veyhl, Wagner et al. 2003, Veyhl, Keller et al. 
2006). PKC regulates SGLT1 by involving modulation in level of cAMP (Hirsch, Loo et al. 
1996). PKC regulates SGLT1 both transcriptionally and post-transcriptionally. This 
regulation might modulate SGLT1 protein level in the apical surface or affect the rate of 
SGLT1 dependent transport. Post transcriptional regulations that can modulate SGLT1 
number in apical surface include changes in trafficking of SGLT1 containing vesicles, 
SGLT1 degradation rate or SGLT1 mRNA stability. The post-transcriptional regulations that 
can alter SGLT1 affinity or turn over number can modulate the rate of SGLT1 mediated 
transport. PKC dependent diverse post-transcriptional modulations have been observed in 
different systems. PKC decreases rabbit SGLT1 turn over number in monkey kidney derived 
fibroblast like cell line (COS-7) (Vayro and Silverman 1999). In Chinese hamster ovary cells 
expressing rabbit SGLT1 (CHO-G6D3), PKC activation lead to increase in transcription of 
SGLT1 mRNA (Castaneda-Sceppa, Subramanian et al. 2010). In LLCPK1 cells, PKC 
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demonstrates a decrease in SGLT1 mRNA due to mRNA degradation (Shioda, Ohta et al. 
1994). In SGLT1 expressing Xenopus laevis oocytes (Hirsch, Loo et al. 1996, Wright, Hirsch 
et al. 1997, Veyhl, Keller et al. 2006), in rat intestinal brush border membrane vesicles 
(Ishikawa, Eguchi et al. 1997), in differentiating human cell clone HT-29-D4 (Delezay, 
Baghdiguian et al. 1995), CHO-G6D3 cell line (Castaneda-Sceppa, Subramanian et al. 2010) 
and LLCPK1 cells (Shioda, Ohta et al. 1994, Peng and Lever 1995) PKC mediates SGLT1 
regulation by modulating exo – and endocytosis of SGLT1 carrying vesicles. The different 
systems not only show different forms of post-transcriptional modulations but also show 
diversity in respect to the effect (increase or decrease) on SGLT1 activity, protein or mRNA 
caused due to PKC activation.  
The different effects caused by PKC on SGLT1 regulation are dependent not only on the 
expression system but also on the species homolog of SGLT1 sequence. In Xenopus laevis 
oocytes expressing rabbit and rat SGLT1, PKC activation mediates a negative regulation 
decreasing the rate of substrate transport whereas when human SGLT1 is expressed it 
mediates a positive regulation increasing substrate transport. The SGLT1 sequence in rat and 
human has 5 consensus PKC sites while rabbit contains 4 sites (Wright, Hirsch et al. 1997). 
The amino acid residues between positions 550-636 of SGLT1 cytoplasmic loop sequence are 
considered to be the most likely domain involved in PKC dependent sequence specific 
regulation of SGLT1. (Hirsch, Loo et al. 1996). Serine 418 residue in hSGLT1 sequence is 
speculated for SGLT1 regulation by phosphorylation/ de-phosphorylation (Kumar, Tyagi et 
al. 2007). These complementary mechanisms for PKC dependent SGLT1 regulation may also 
depend on the choice of path followed. The activation of MAPK and PI3K/Akt/mTOR 
signalling pathway by PKC lead to increase in SGLT1 dependent uptake. The activation of 
p38/MAPK signalling pathway by PKC exerts the inhibitory action on SGLT1 uptake 
(Castaneda-Sceppa, Subramanian et al. 2010).  
The further investigation of PKC in the transcriptional and posttranscriptional regulatory 
mechanism of RS1 may bring new insights in understanding SGLT1 regulation and thereby 
might impart knowledge for the better management of carbohydrate metabolism. 
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2. Aim of the study: 
The aim of this study was to further elucidate the role of the regulatory protein RS1 in the 
short term post-translational and long term transcriptional regulation of SGLT1by employing 
tools which were available in the laboratory of Professor H. Koepsell. These tools were mice 
in which RS1 was removed genetically (RS1-/- mice) and tripeptides derived from the 
regulatory domain of RS1 which mediates post-translational regulation of SGLT1. Since it is 
known that post-translational regulation of SGLT1 is modulated by PKC (Hirsch, Loo et al. 
1996, Wright, Hirsch et al. 1997) and that PKC also influences the post-translational 
regulation mediated by RS1 (Veyhl, Wagner et al. 2003) the effect of PKC in wild type mice 
versus RS1-/- mice was compared. Concerning investigation of the role of RS1 in 
transcriptional regulation the present study was focussed on the investigation of effects of 
diets on the expression of SGLT1 in small intestine. Due to restriction of time and technical 
difficulties arising during the study the investigation was focussed on functional analyses.  
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3. Materials & Methods 
3.1 Materials 
3.1.1 Chemicals:  
All laboratory chemicals used were of pro analysi (p.a.) grade and were purchased form one 
of the firms namely Sigma-Aldrich (Taufkirchen, Germany), Merck (Darmstadt, Germany), 
Perkin Elmer (Darmstadt, Germany) or AppliChem (Darmstadt, Germany). 
3.1.2 Animals:  
Institutional guidelines and German laws were met in order to handle mice as the model 
system. Wild type mice and RS1-/- mice of 129/OLA/C57BL/6 or C57BL/6 background 
were used for comparative studies on SGLT1 activity. Animals of age 2 – 3 months were 
chosen for study. All animals were housed in a temperature – controlled environment with a 
12h – light/12h – dark cycle with free access to specific diet and tap water.  
3.1.3 Diets:  
For the study of diet effects on SGLT1 regulation, weaning mice of 10-14 days old were 
segregated to different groups. Each group were fed with free access to specific diet and tap 
water for 2 months. Standard control or normal diet (ND) (Ssniff V1534-000R/M-H, 10mm), 
High fat high glucose diet (HFHGD) (Ssniff® EF R/M by D12492 mod.) and Glucose-
galactose reduced diet (GGRD) (Ssniff® EF R/M Glucose-arm) were purchased from 
Spezialdiäten GmbH, (Soest, Germany).  The specific composition of each diet is mentioned 
in (table 1) and their total metabolizable energy is mentioned in (table 2) 
Table – 1: Diet composition 
Diet 
Components 
Standard 
control diet 
(%) 
High fat high 
glucose diet 
(%) 
Glucose-
galactose 
reduced diet (%) 
Starch 36.4 2.2 5.8 
Protein 19 24.1 29.7 
Fibre 4.9 6 28.8 
Mono and Di 
saccharides 
4.7 22.4 0.5 
Fat, Minerals, Vitamins 3.3 34 20.5 
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Table -2: Total metabolizable energy  
 Standard control 
diet (MJ/kg) 
High fat high 
glucose diet 
(MJ/kg) 
Glucose-galactose 
reduced diet 
(MJ/kg) 
Total 
metabolizable 
energy 
12.8 25.2 22.9 
3.1.4 Inhibitors and Activators: 
Protease inhibitors used for the study were obtained from Roche Diagnostics Deutschland 
GmbH (Mannheim, Germany). The working concentrations of the same are specified in the 
following table. 
Table -3: Working stock concentration of protease inhibitor: 
Protease Inhibitor Working concentration (µM) 
Aprotinin 0.8 
Benzamidin 1000 
Leupeptin 20 
Phenylmethylsulfonyl fluoride (PMSF) 100 
Pefabloc SC (AEBSF) 2000 
Phorbol 12 - myristate 13 - acetate (PMA) which is an activator of PKC was obtained from 
the firm Sigma-Aldrich (Taufkirchen, Germany). The working concentration of the PMA 
used was 5 µM.  
3.1.5 Synthetic tripeptides: 
Two synthetic tripeptides QSP (Gln-Ser-Pro) and QEP (Gln-Glu-Pro) were obtained from the 
lab of Dr. Rüdiger Pipkorn, German Cancer Research Center (Heidelberg, Germany). The 
working concentration of the peptides used was 15 mM. 
3.1.6 Radioactive substrate: 
ARC0131 C
14
 radiolabelled Methyl–α-D-Glucopyranoside (AMG), [glucose-14C (U)]; (11.1 
Gbq/mMol) was obtained from American Radiolabeled Chemicals, Inc. (St. Louis, MO, 
USA). Radioactive [
14
C] AMG was added in tracer amounts to a required concentration of 
AMG for performing SGLT1 uptake and affinity studies. The final AMG working 
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concentration for uptake studies in everted segment method was 10 µM while for affinity 
measurements in brush border membrane vesicles (BBMV), a concentration range from 0.02 
– 5 mM was used. 
3.1.7 Buffers and solutions: 
Deionised water was used to prepare all aqueous buffer solutions. Compositions of the 
different buffer solutions are mentioned in the respective method sections. 
3.1.8 Software: 
Putative phosphorylation motifs in TGN-Reg domain of human and mice RS1 sequence were 
searched using MnM 3.0 (Minimotif Miner, version 3.0)(http://minimotifminer.org) and GPS 
2.1 (Group-based Prediction System, version 2.1) (http://gps.biocuckoo.org) software. 
Statistical analyses were performed using PRISM (GraphPad software, Inc., San Diego, 
Calif.) software. 
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3.2 Methods 
3.2.1 Small intestinal brush border membrane vesicle (BBMV) preparation:  
Isolation of BBMVs was performed using a modified magnesium precipitation - 
centrifugation procedure (Koepsell, Fritzsch et al. 1990). 
Each set of BBMV preparation required 3 mice. The mice were starved for 24 hours prior to 
use for BBMV preparation. Small intestine from these mice were isolated, everted and 
washed either directly with 20 ml ice cold homogenization buffer or after incubation for 1 
hour at 37°C in a shaking water bath under different study conditions. After washing, the 
small intestines were mechanically homogenized using the Power Gen 125 homogenizer 
(Fischer Scientific, Waltham, Massachusetts, USA). The homogenization was performed in 
35 ml ice cold homogenization buffer with protease inhibitors. The homogenate obtained was 
precipitated after adding magnesium chloride (MgCl2) to a final concentration of 10 mM. For 
precipitation the homogenate was incubated with MgCl2 for 20 min in ice with intermittent 
shaking at every 5 min. The precipitated homogenate was centrifuged at 3000 relative 
centrifugal force (rcf), 4°C for 15 min in a super speed centrifuge (Sorvall® Evolution RC 
centrifuge, Thermo Fisher Scientific, Langenselbold, Germany) using rotor SS-34. Pellet 
containing mitochondria and nuclei was discarded and the remaining supernatant was 
centrifuged for 30 min at 27000 rcf, 4°C. 35 ml of ice cold vesicle buffer containing protease 
inhibitor was added to the resulting pellet and homogenized using glass Potter Elvehjem 
homogenizer (Sartorius, Gottingen, Germany). The homogenate was centrifuged for 30 min 
at 27000 rcf, 4°C and the pellet was collected. To this pellet 300 µl of ice cold vesicle buffer 
with protease inhibitors was added and it was aspirated using syringe with needle having pore 
size 26G x 3/8”. The BBMVs of each preparation were divided in 3-4 portions and stored in 
liquid nitrogen until use. 
 
Homogenization buffer (100 mM mannitol, 2 mM Hepes) pH 7.1 
adjusted using 1 M Tris 
Vesicle buffer (100 mM mannitol, 20 mM Hepes) pH 7.4 
adjusted using 1 M Tris 
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3.2.2 AMG affinity uptake in BBMVs: 
Substrate uptake in BBMVs was performed using rapid filtration technique (Hopfer, Nelson 
et al. 1973).  
Aliquots of 2-3 different BBMV preparations for the same condition were thawed at 37°C in 
a water bath and pooled to overcome differences between preparations. Hence each 
preparation used for uptake measurement was freeze-thawed only once. AMG, an SGLT 
specific non-metabolizing substrate, was used at concentrations 0.02 – 5 mM, to measure the 
substrate dependence of SGLT1 mediated glucose transport. Different AMG concentrations 
were prepared with tracer amount of [
14
C] AMG in uptake buffer containing either 100 mM 
sodium thiocyanate or 100 mM potassium thiocyanate. Sodium dependent uptake 
measurements were performed by incubating 20 µl BBMV for 2 seconds in 50 µl of sodium 
or potassium containing uptake buffer with different concentrations of AMG. Uptake in the 
presence of sodium was blocked with 1 ml ice cold stop buffer containing 100 mM sodium 
chloride plus 0.2 mM phlorizin. Uptake measured in the absence of sodium was stopped 
using 1 ml ice cold stop buffer containing 100 mM potassium chloride. The vesicles were 
washed on nitrocellulose membrane filters using respective ice cold blocking buffer. The 
filters were transferred into 5 ml scintillation vials. 1ml of scintillation fluid - Lumasafe 
scintillation cocktail (Lumac LSC (Groningen, Netherlands) was added and the vials were 
placed in a shaker for 1 hour for mixing.  The radioactivity on the filters was measured using 
Beckman Coulter TM LS 6500 Multi-purpose scintillation counter (Beckman Coulter, Inc., 
Fullerton, CA, USA).  
Na
+
 containing uptake buffer 100 mM mannitol, 20 mM Hepes, 100 mM 
sodium thiocynate pH 7.4 adjusted with 1 M 
Tris 
K
+
 containing uptake buffer 100 mM mannitol, 20 mM Hepes, 100 mM 
potassium thiocynate pH 7.4 adjusted with 1 
M Tris 
Na
+
 containing stop buffer 100 mM mannitol, 20 mM Hepes, 100 mM 
sodium hydroxide pH 7.4 adjusted with 5 M 
sodium hydroxide 
K
+
 containing stop buffer 100 mM mannitol, 20 mM Hepes, 100 mM 
potassium hydroxide pH 7.4 adjusted with 5 
M potassium hydroxide 
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3.2.3  Protein estimation in BBMVs: 
To measure the amount of protein in BBMV preparations, Lowry’s method for protein 
estimation was used (Lowry, Rosebrough et al. 1951).  
Bovine serum albumin (BSA) at concentrations 5 µg, 10 µg, 20 µg and 40 µg were used as 
controls. BBMV samples to be analysed were diluted 17.5 times in 0.5 % sodium dodecyl 
sulphate (SDS) and 100 µl was taken for analysis. 1 ml Lowry solution was added to both 
samples and controls and incubated for 10 min. Later 100 µl of 1 X Folic and Ciocalteu’s 
phenol reagent was added and vortexed. The controls and samples were incubated for 30 
minutes at room temperature and measured for optical density at absorbance of 760 nm 
wavelength using tungsten light in Pharmacia LKB Ultraspec III UV/visible scanning 
spectrophotometer (Pharmacia Biotech, Uppsala, Sweden). A graph was plotted using the 
values of optical density measured against control concentrations and the slope, y = m(x) + c, 
(where y = optical density values, x = unknown concentration and m and c are linear equation 
constants) was obtained. Using this slope, sample concentration was determined in µg/µl 
after correcting to dilution factor and sample volume. 
3.2.4 AMG uptake in small intestinal everted segments: 
Mice were starved for 24 hours and AMG uptake measurements were performed in small 
intestinal everted segments at 10 am.  
To determine the distribution of SGLT1 activity along the small intestine segments from 
duodenum (2-6 cm distal to pylorus), jejunum (8-12 cm distal to pylorus) and ileum (4-8 cm 
proximal to ileocecal valve) were used. Short term regulation of SGLT1 mediated transport 
was studied using jejunal segments derived from 6 cm – 14 cm distal to pylorus. The small 
intestine isolated from the mice was first washed with Krebs ringer solution (20 ml) kept at 
room temperature. The small intestine from mice was then everted using a steel rod and 1 cm 
long segments of the above defined regions were dissected. The Krebs ringer buffer used for 
AMG uptake was bubbled for few seconds with 95% O2 5% CO2 gas. AMG uptake into the 
mucosa of the segments was either measured directly or after the segments had been pre-
incubated under different study conditions for 1 hour at 37°C in a shaking water bath. 
Lowry solution Lowry’s reagent (2 % sodium carbonate, 0.4 
% sodium hydroxide) + 0.02 % potassium 
sodium tartarate + 0.01 % copper sulphate 
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Phlorizin inhibitable uptake of AMG was measured after 2 min incubation at 37°C in shaking 
water bath in Krebs ringer buffer containing 10 µM [
14
C] AMG without or with 1 mM 
phlorizin  Uptake was stopped by incubating the segments for 5 min in ice cold Krebs ringer 
buffer containing 1 mM phlorizin. The segments were washed on a nitrocellulose filter with 
ice-cold Krebs ringer buffer. The accurate length of the individual segments was determined 
under a light microscope using a 1/10 mm scale. The segments were dissolved in 500 µl of 
tissue solubilizer - Soluene® 350 (PerkinElmer, Massachusetts, USA) by heating them in a 
water bath at 60°C for 2 hours. 200 µl from each dissolved sample was taken in duplicates 
into 5 ml scintillation vials. 1 ml of scintillation fluid - Lumasafe scintillation cocktail 
(Lumac LSC, Groningen, Netherlands) was added and the vials were placed in a shaker for 1 
hour for mixing. The radioactivity of the dissolved samples was measured was measured 
using Beckman Coulter TM LS 6500 Multi-purpose scintillation counter (Beckman Coulter, 
Inc., Fullerton, CA, USA).  
Krebs Ringer solution (10 mM Hepes, 103 mM sodium chloride, 
4.8 mM potassium chloride, 1.2 mM 
magnesium sulphate, 1.2 mM potassium di-
hydrogen phosphate, 1.2 mM calcium 
chloride) pH 7.35 adjusted with 5 M sodium 
hydroxide 
Krebs Ringer solution for pre-incubation  (10 mM Hepes, 103 mM sodium chloride, 
4.8 mM potassium chloride, 1.2 mM 
magnesium sulphate, 1.2 mM potassium di-
hydrogen phosphate, 1.2 mM calcium 
chloride, 5 mM MES) pH 6.5 adjusted with 5 
M sodium hydroxide 
3.2.5 Calculation and Statistics 
Uptake measurements in everted segments of small intestine were performed at least in 3 
mice for every condition. The radioactive measurements were calculated in Picomoles/cm/2 
min. The uptake measurements were normalized twice in order to overcome two types of 
variations. One variation was the technical difference in controls measured on different days. 
The other variation was the segmental difference within a particular region of small intestine 
(Appendix III). The measurement obtained for the control segment in the different mice used 
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per day was averaged. This average value was used to normalize the other conditions 
measured in the different segments of these mice. These values were then re-normalized 
according to the regional segmental difference. The mean value ± standard error obtained for 
the twice normalized values were compared between wild type or RS1-/- control to 
understand the effect of a particular study condition.  
Aliquots from different BBMV preparations of the same conditions were thawed and pooled 
for affinity measurements. This was done to avoid the variation between individual BBMV 
preparations. At least two different BBMV preparations were pooled for every affinity 
uptake. Sodium dependent SGLT1 affinity uptake was assayed at least 3 times. The 
radioactive counts measured for every affinity assay were determined in Picomoles/mg/2 
seconds. These values of each assay were fitted in non-linear regression to obtain Km value 
using the Michaelis-Menten enzyme kinetic equation (Y=Vmax*X/(Km+X); where X 
symbolizes the different AMG concentrations and Y is the relative transport velocity 
obtained). Sodium-dependent uptake rates of individual experiments were normalized to the 
respective Vmax values. The mean uptake rates ± standard error values obtained from 
independent experiments was represented in non-linear Michaelis-Menten curve and the Km. 
value was obtained. To find the change in SGLT1 affinity, the Km values obtained from 
independent experiments of different conditions were compared.  
Significance of difference between standard error of mean (SEM) of three or more groups 
were tested using one way ANOVA with post hoc Tukey comparison, marked as asterisk (*). 
Significance of difference between SEM values of two groups was calculated using one sided 
student’s unpaired or paired t-test. One sided student’s t test was used for comparing the 
effect of difference in respect to only control condition. Unpaired t-test was used when 
different mice sample SEM values were compared and significant differences were marked 
with exclamation (!). Paired t-test was done to compare differences between segment SEM 
values of the same mice subjected to different conditions and significant differences were 
marked as section sign (§).  
3.2.6 Experimental design setup: 
The mechanism underlying RS1 dependent and independent short term and long term 
regulation of SGLT1 in mouse system was investigated in the present study.   
SGLT1 activity and affinity for transport were assessed in wild type and RS1-/- mice. For 
estimating SGLT1 activity, phlorizin inhibited uptake of 10 µM AMG, labelled with tracer 
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amount of [
14
C] AMG was performed in everted segments of mice small intestine. Affinity of 
SGLT1 was determined by measuring Na
+
 specific uptake at different concentrations of 
AMG, labelled with tracer amount of [
14
C] AMG, in brush border membrane vesicles of mice 
small intestine.  
Short term regulation of SGLT1 was studied after 1 hour pre-incubation of mice small 
intestine in presence and absence of glucose. For understanding diet adaptations of SGLT1 
direct measurements were performed in mice subjected to diets varied in their glucose 
content. RS1 dependent regulation for these changes was studied by measuring the difference 
in SGLT1 mediated AMG uptake and kinetics in small intestine of wild type and RS1-/- 
mice. Further study was done to characterize RS1 in the role of short term SGLT1 regulation 
by using its functional tripeptide QSP (Vernaleken, Veyhl et al. 2007) and its 
phosphorylation mimicking mutant QEP. Since RS1 has many putative phosphorylation sites 
(Figure 2) and its regulation of SGLT1 is known to be PKC dependent (Veyhl, Wagner et al. 
2003), the role of PKC in RS1 dependent SGLT1 short term regulation was also investigated. 
QSP has a CamKII phosphorylation putative site (Figure 2) hence the addition of QSP 
phosphorylation with PKC activation was also studied to infer whether they follow a 
common pathway for mediating SGLT1 short term regulation. Since PKC is also known for 
its role as a post-transcriptional regulator of SGLT1 (Wright, Hirsch et al. 1997) the effect of 
PKC on SGLT1 affinity for transport was checked to understand its mechanism of regulation.  
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4. Results 
In this study attempt was made to improve the understanding of glucose in short term and 
long term regulation of SGLT1. In particular, effort was made to understand better, the 
dependence of the regulator protein RS1 in these regulations. For this, functional studies were 
performed in wild type and RS1-/- mice in combination with application of the RS1 derived 
regulatory tripeptide QSP. In addition, experiments were also made to elucidate the role of 
PKC in RS1 dependent short term regulation of SGLT1.  
4.1 Effect of glucose and RS1 on SGLT1 activity: 
SGLT1 plays a pivotal role in small intestine for regulation of glucose absorption. After 
application of D-glucose in mice by gavage in vivo and analyses of glucose transport in 
isolated brush-border membrane vesicles (BBMV) it has been shown that glucose bolus 
increases the amount and transport activity of SGLT1 in wild type mice (Gorboulev, 
Schurmann et al. 2012). On the other hand mice lacking RSC1A1 gene which shows 
enhanced glucose absorption in small intestine in brush border membrane (BBM) and 
increased amount of SGLT1 protein in plasma membrane enriched (PME) fractions 
(Osswald, Baumgarten et al. 2005), did not show any further increase in SGLT1 amount and 
activity in the BBM after gavage with glucose. The upregulation of SGLT1 in wild type mice 
after a glucose bolus equals SGLT1 activity of RS1-/- mice (H. Kipp and H. Koepsell, 
unpublished data). RS1 is involved in the post-transcriptional short term regulation of SGLT1 
in a glucose dependent manner (Veyhl, Keller et al. 2006). 
In my study the effects of RS1 removal or incubation with D-Glucose on SGLT1 mediated 
transport activity was investigated by performing uptake measurement in everted small 
intestinal segments. These measurements allowed more direct control of the experimental 
conditions such as luminal glucose concentrations compared to in vivo gavage with D-
glucose. However this experimental setup had the drawback that pre-incubation of the 
everted small intestinal segments led to decrease in SGLT1 activity (Appendix I). In figure 3 
the phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG 
was measured in everted jejunal segments of wild type and RS1-/- mice after pre-incubating 
them in the presence or absence of 5 mM D-glucose. In the absence of glucose, AMG uptake 
was slightly higher in RS1-/- mice, compared to wild type mice. In the presence of glucose, 
AMG uptake was increased in wild type and RS1-/- mice. This increase reached the same 
level of transport activity in both cases. The data are consistent with the uptake measurements 
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in isolated BBMV obtained after glucose gavage, with the exception that the activity of 
SGLT1 in the absence of glucose in RS1-/- mice was smaller, compared to activity in the 
presence of glucose observed in wild type mice. 
 
Figure 3: Glucose alters SGLT1 activity: Wild type (   ) and RS1-/- mice (   ) were starved 
for 24 hours prior to measuring SGLT1 dependent uptake. Phlorizin inhibited uptake of 10 
µM AMG, labelled with tracer amount of [
14
C] AMG was measured for 2 minutes in everted 
segments of mice jejunum after pre-incubating the segment in buffer or 5 mM glucose for 1 
hour. Radioactivity in the segments was measured and was calculated in terms of 
picomoles/cm/2 min. RS1-/- mice showed elevated AMG uptake in comparison to wild type 
mice (P=0.0294) by 1 sided, un-paired t test, marked by exclamation (!). Glucose effect in 
wild type mice was highly significant (p<0.001) by ANOVA test, indicated by asterisk (*). 
Glucose effect in RS1-/- mice was slightly significant (P = 0.0116). The SGLT1 activity 
observed in RS1-/- mice in absence of glucose was smaller compared to activity in wild type 
mice in presence of glucose (P = 0.0047). 
4.2 Effect of glucose and RS1 on SGLT1 affinity: 
To determine whether the up-regulation of SGLT1 activity observed after removal of RS1 
and/or after pre-incubation with glucose include changes of SGLT1 affinity, the substrate 
dependence of SGLT1 mediated AMG uptake in isolated BBMVs was measured. Pre-
incubation of everted small intestine segments for 1 hour led to decreased SGLT1 activity but 
did not change the Michaelis Menten (Km) values for AMG uptake into BBMV (Appendix I 
and II). Hence Km values for AMG uptake were measured using BBMVs prepared from small 
intestines of mice which had been either pre-incubated for 1 hour with 5 mM D-glucose or 
were not pre-incubated. AMG uptake measurements for 2 seconds were performed at AMG 
concentrations (0.02 – 7.14 mM) containing tracer amount of [14C] AMG in the presence and 
) ) 
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absence of 100 mM sodium. Based on the obtained sodium dependent uptake rates, the Km 
values were calculated. The data presented in Figure 4A and 4B indicate similar Km values 
for AMG uptake in RS1-/- mice compared to wild type mice. They showed that the Km values 
in RS1-/- and wild type mice were significantly increased when the small intestines had been 
pre-incubated with D-glucose. This indicated that the glucose dependent up-regulation of 
SGLT1 in BBM is correlated with a decrease in affinity which appears to be independent of 
RS1. Thus my data suggested a RS1 independent strong glucose induced increase of SGLT1 
in the BBM.  
 
Figure 4: Glucose alters SGLT1 affinity independent of RS1: Wild type and RS1-/- mice 
were starved for 24 hours prior to BBMV preparation. Sodium dependent uptake 
measurements were performed for 2 sec in BBMVs incubated in Na
+
 containing buffer and 
K
+
 containing buffer at different radioactive AMG concentrations (0.02 – 7.14 mM). 
Radioactivity measured for uptake was calculated in picomoles/mg/2 seconds. The values 
obtained were analysed using Michael-Menten equation to determine the Km value. Figure 4A 
represents the sodium-dependent uptake rates of individual experiments that were normalized 
to the respective Vmax values. Mean ± standard error values from independent experiments 
are shown. Figure 4B represents the comparison between Km values for sodium-dependent 
AMG uptake into BBMVs. Significant difference was observed between Km values after pre-
incubation with glucose and no pre-incubation in wild type (P=0.0485) and RS1-/- mice 
(P=0.0004) by 1 sided, un-paired t test (!). The SGLT1 affinity in wild type and RS1-/- mice 
did not differ (P=0.1202) by 1 sided, un-paired t test. 
4.3 Effect of regulatory tripeptides (QSP and QEP) on glucose dependent short term 
regulation of SGLT1: 
In small intestine, RS1 down-regulates the amount of SGLT1 in the BBM if the glucose 
concentration in small intestine lumen is low. In the presence of high glucose concentration 
in the intestine lumen, the RS1 dependent down-regulation is reduced, resulting in a higher 
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expression of SGLT1 (H.Kipp and H. Koepsell, unpublished data) . The TGN-Reg domain of 
human RS1 which mediates post-transcriptional down-regulation contains two copies of the 
active motif - QSP (figure 2).  The data of Prashanth R Reddy and Alexandra Friedrich 
suggest that QSP and its phosphorylation mimicking variant QEP do not down-regulate 
SGLT1 in small intestine of wild type mice when the glucose concentration in the lumen is 
low, because the endogenous RS1 is effective under this circumstance (Prashanth Reddy, 
Alexandra Friedrich, Hermann Koepsell, unpublished data). Experiments of Maike Veyhl-
Wichmann indicate that the affinity of QEP to down-regulate human SGLT1 expressed in 
oocytes of Xenopus laevis is higher, compared to QSP (M. Vehyl-Wichmann, Prashanth R. 
Reddy, A. Friedrich and H. Koepsell, unpublished data). In figure 5 I investigated whether 
the SGLT1 mediated glucose transport in small intestine of wild type and RS1-/- mice was 
down-regulated after pre-incubation without and with 5 mM D-glucose without or with 15 
mM QSP. Phlorizin inhibited uptake of 10 µM AMG was measured in everted segments of 
mice small intestine. The measurements were normalized to the uptake after pre-incubation 
of small intestine everted segments of wild type mice or RS1-/- mice in buffer (Figure 5A and 
5B) or D-glucose (Figure 5C and 5D).  The mean ± standard error  values in picomoles/cm/2 
min used for normalization were: wild type mice pre-incubation without glucose 291.9 ± 
15.67, RS1-/- mice pre-incubation without glucose 296.2 ± 13.47, wild type mice pre-
incubation with glucose 324.5 ± 12.02, RS1-/- mice pre-incubation with glucose 354.2 ± 
36.69. The results indicated a border line significance for glucose dependent up-regulation in 
wild type (P = 0.1843) and RS1-/- mice (P = 0.0728) (data not shown) which suggested the 
glucose dependent up-regulation of SGLT1 to be independent of RS1. The data represented 
in Figure 5 indicated significant down-regulation of SGLT1 dependent AMG uptake in wild 
type and RS1-/- mice after pre-incubation with 15 mM QSP in the absence as well as in the 
presence of 5 mM D-glucose. The effect observed in wild type mice in the absence of glucose 
was unexpected (see discussion). 
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Figure 5: QSP at 15 mM concentration mediated down regulation of SGLT1 activity 
independent of glucose: Wild type and RS1-/- mice were starved for 24 hours prior to 
measuring SGLT1 dependent uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled 
with tracer amount of [
14
C] AMG was measured for 2 minutes in everted jejunum segments 
of wild type mice (Figure5 A and C) and RS1-/- mice (Figure5 B and D). The segments were 
pre-incubated in buffer (Figure5 A and B) or in glucose (Figure5 C and D) with or without 15 
mM QSP for 1 hour. Radioactivity was calculated in terms of Picomoles/cm/2 min and 
normalized to wild type or RS1-/- mice in buffer or glucose control respectively. QSP 
significantly down-regulated AMG uptake in wild type and RS1-/- mice independent of 
glucose (P < 0.01 by 1 sided paired t test, marked by section sign (§)). 
Since QEP has a higher affinity than QSP to post-transcriptionally down-regulate human 
SGLT1 expressed in oocytes of Xenopus laevis, I investigated whether the down-regulation 
of SGLT1 in small intestine of wild type mice after pre-incubation in 5 mM D-glucose with 
15 mM QEP was more pronounced compared to 15 mM QSP (Figure 6). Only wild type mice 
Results 
 
25 
 
were considered for this measurement as QSP down regulated SGLT1 in wild type and RS1-
/- mice in the presence of 5 mM D-glucose (Figure 5 C and 5 D). The phlorizin inhibited 10 
µM AMG uptake measurements were normalized to pre-incubation in glucose condition of 
wild type mice in the absence of tripeptides (Figure 6). The mean ± standard error values in 
picomoles/cm/2 min used for normalization of wild type mice segments pre-incubated with 
glucose was 293.9 ± 11.36. The results showed that 15 mM QSP and QEP significantly 
down-regulated SGLT1 dependent AMG uptake in wild type mice. No significant difference 
was observed between QSP and QEP mediated down regulation in wild type mice (P 
=0.3426, 1 sided un-paired t test). This indicated that QSP and QEP were equally effective at 
the employed concentration and experimental conditions.   
 
Figure 6: QSP and QEP at 15 mM concentration are equipotent in mediating down 
regulation of SGLT1: Wild type mice were starved for 24 hours prior to performing SGLT1 
dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer 
amount of [
14
C] AMG was measured for 2 minutes in everted jejunum segments of wild type 
mice after pre-incubating the segments in glucose with or without 15 mM concentration of 
tripeptide for 1 hour. Radioactivity was calculated in terms of Picomoles/cm/2 min and 
normalized to mice glucose control. QSP and QEP down regulate AMG uptake with a 
significance of (P = 0.0212) and (P = 0.0155) respectively by 1 sided un-paired t test marked 
by exclamation mark (!). 
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4.4 The role of PKC in RS1 dependent short term regulation of SGLT1: 
PKC activation is involved in the post-transcriptional short term regulation of SGLT1 
(Wright, Hirsch et al. 1997, Vayro and Silverman 1999, Castaneda-Sceppa, Subramanian et 
al. 2010). Previously, data were obtained showing that the activation of PKC influences the 
regulation of total RS1 protein on the human SGLT1 expressed in Xenopus laevis oocytes 
(Veyhl, Wagner et al. 2003, Veyhl, Keller et al. 2006). Since the TGN-Reg domain of mouse 
RS1 contains many putative phosphorylation sites for protein kinases including PKC (Figure 
2), the previously observed effect of PKC activation could be due to activation of the TGN-
Reg by phosphorylation. To investigate whether the short term down-regulation by RS1 on 
SGLT1 is PKC dependent in mouse small intestine, the effect of PKC activation on SGLT1 
dependent AMG uptake was performed in wild type and RS1-/- mice. Everted segments of 
wild type and RS1-/- mice small intestine  were pre-incubated for 1 hour in buffer or 5 mM 
D-glucose with or without 5 µM Phorbol 12-myristate 13-acetate (PMA), an activator of 
PKC (Castagna, Takai et al. 1982)). The phlorizin inhibited AMG uptake was measured in 
these everted segments. The measurements were normalized to pre-incubation in buffer 
(Figure 7A and B) or glucose (Figure 7C and D) condition of wild type (Figure 7A and C) 
and RS1-/- (Figure 7B and D) mice respectively. The mean ± standard error values in 
picomoles/cm/2 min used for normalization were: wild type mice pre-incubation without 
glucose 206.1 ± 26.52, RS1-/- mice pre-incubation without glucose 276.7 ± 27.39, wild type 
mice pre-incubation with glucose 295.0 ± 12.29, RS1-/- mice pre-incubation with glucose 
296.6 ± 12.75. The data (Figure 7) showed a 20-30% down-regulation of SGLT1 dependent 
AMG uptake in wild type and RS1-/- mice after pre-incubation with 5 µM PMA which was 
independent of pre-incubation with 5 mM D-glucose. This indicated a PKC dependent short 
term down-regulation of SGLT1 which appeared to be independent of RS1 as well as 
glucose. 
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Figure 7: PKC down-regulated SGLT1 activity independent of glucose and RS1: Wild 
type and RS1-/- mice were starved for 24 hours prior to performing SGLT1 dependent AMG 
uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG 
was measured for 2 minutes in everted jejunum segments of wild type mice (Figure 7A and 
7C) and RS1-/- mice (Figure 7B and 7D) after pre-incubating the segment in buffer (Figure 
7A and 7B) or glucose (Figure 7C and 7D) with or without 5 µM PMA for 1 hour. 
Radioactivity was calculated in terms of Picomoles/cm/2 min and normalized to wild type or 
RS1-/- mice in buffer or glucose control respectively. PKC when incubated with or without 
glucose was able to significantly down- regulate SGLT1 activity in wild type and RS1 -/- 
mice (§).  
If short term down-regulation via RS1 and PKC are mediated by independent mechanisms, 
then the down-regulation of SGLT1 by both together should be additive. To test this I studied 
additive effects of QEP and PKC activation in everted segments of small intestine of wild 
Results 
 
28 
 
type and RS1-/- mice. Employing only the TGN-Reg modified motif QEP, the effect of PKC 
on the entire TGN-Reg domain was excluded. The measurements were performed in the 
presence of 5 mM D-glucose, as the endogenous RS1 in wild type mice is expected to be less 
active under this condition. Everted segments of mice jejunum were pre-incubated in 5 mM 
D-glucose either in the presence of 15 mM QEP or 5 µM PMA alone or QEP with PMA for 1 
hour. The experiments were performed in wild type mice (Figure 8 A) and RS1-/- mice 
(Figure 8 B). Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] 
AMG was measured. The data were normalized to control AMG uptake after pre-incubation 
with D-glucose without QEP and PMA in wild type and RS1-/- mice respectively. The mean 
± standard error values in picomoles/cm/2 min used for normalization were: wild type mice 
pre-incubation with glucose 293.9 ± 11.36 and RS1-/- mice pre-incubation with glucose 
289.5 ± 10.45. The data showed no additive inhibition of SGLT1 activity mediated by PMA 
with QEP over QEP or PMA alone in wild type and RS1-/- mice. Since PMA inhibition was 
independent of RS1 (figure 7), the short term down-regulation of SGLT1 by RS1 and PKC 
suggested independent phenomenon for the same pathway of inhibition.  
 
Figure 8: PKC has no additive effect on QEP dependent short term regulation of 
SGLT1: Wild type and RS1-/- mice were starved for 24 hours prior to performing SGLT1 
dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer 
amount of [
14
C] AMG was measured for 2 minutes in everted jejunum segments of wild type 
mice (Figure 8 A) and RS1-/- mice (Figure 8 B) after pre-incubating the segment in glucose 
with or without QEP, PMA and QEP + PMA for 1 hour. Radioactivity was calculated in 
terms of Picomoles/cm/2 min and normalized to wild type or RS1-/- mice in glucose control 
respectively. QEP with PMA showed no additive inhibition to QEP or PMA alone in wild 
type and RS1-/- mice.  
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4.5 Effect of PKC on SGLT1 affinity: 
Trying to elucidate how PKC activation down-regulates SGLT1 mediated AMG uptake in 
small intestinal brush border membranes (BBM), we wondered whether the Michaelis 
Menten (Km) value for SGLT1 dependent AMG uptake was altered. The Km value of sodium 
dependent AMG uptake was measured in brush border membrane vesicles (BBMVs) which 
were isolated from small intestine of RS1-/- mice pre-incubated without or with 5 mM D-
glucose. BBMVs isolated from small intestine of RS1-/- mice were used because PKC effect 
appeared to be independent of RS1 (Figure 7). In these experimental series the pre-incubation 
of small intestine in the absence of glucose was performed in the presence of 9 mM sodium 
pyruvate for trying to avoid intracellular ATP depletion. Control experiments had suggested 
that sodium pyruvate exhibited some protection against SGLT1 inactivation during the pre-
incubation period (Appendix I) without altering the Km value for SGLT1 dependent AMG 
uptake (Appendix II). Small intestines were pre-incubated for 1 hour with 9 mM sodium 
pyruvate or 5 mM D-glucose with or without 5 µM PMA and BBMVs were isolated. Sodium 
dependent AMG uptake measurements were performed at AMG concentrations (0.02 – 5 
mM) containing tracer amount of [
14
C] AMG using an incubation time of 2 seconds. Uptake 
rates per mg protein were calculated (picomoles/mg/2 seconds).  
Km values were determined by fitting the Michael-Menten equation to the uptake rates 
obtained (Figure 9). The data indicated that the Km value for SGLT1 mediated AMG uptake 
was decreased when PKC was active. In my experiment this effect was significant in the 
presence of glucose. Noteworthy the decrease of Km after stimulation of PKC resulted in 
decrease of 10 µM AMG uptake mediated by SGLT1. Thus the data suggested that PKC 
stimulation might affect either the turnover number or amount of functional active SGLT1 at 
the BBM.  
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Figure 9: PKC altered SGLT1 affinity: Wild type and RS1-/- mice were starved for 24 
hours prior to BBMV preparation. BBMVs were prepared after pre-incubation in 5 mM 
glucose or 9 mM sodium pyruvate with or without 5µM PMA for 1 hour. Sodium dependent 
uptake measurements were performed for 2 sec in BBMVs incubated in Na
+
 containing 
buffer and K
+
 containing buffer at different radioactive AMG concentrations (0.02 – 5 mM). 
Figure 9A represents the sodium-dependent uptake rates of individual experiments that were 
normalized to the respective Vmax values. Mean ± standard error values from independent 
experiments are shown. Figure 9B represents the comparison between Km values for sodium-
dependent AMG uptake into BBMVs. Border line significance was observed for the 
difference between Km values of BBMVs prepared with pre-incubation with sodium pyruvate 
with or without PMA, P = 0.1356, 1 sided un-paired t test. Significant difference was 
observed between Km values of BBMVs prepared with pre-incubation with glucose in 
presence or absence of PMA, P = 0.0019, 1 sided un-paired t test (!).  
4.6 Effect of RS1 on SGLT1 activity during diet adaptation: 
Diet dependent long term up-regulation of SGLT1 in small intestine increases the capacity 
for glucose absorption during high carbohydrate content in food (Shirazi-Beechey, Hirayama 
et al. 1991, Moran, Al-Rammahi et al. 2010). This glucose dependent regulation is influenced 
by types of ingested carbohydrate and is influenced by extrinsic factors (Luz Sdos, de 
Campos et al. 1997). Because RS1 is involved in the transcriptional regulation of SGLT1 and 
preliminary data suggest RS1 to influence SGLT1 regulation in mouse small intestine in 
response to hyper-caloric, fat rich but glucose-galactose reduced diet (GGRD, see Table 1) 
(Filatova, Leyerer et al. 2009), we compared the transport activity in different small intestinal 
segments of wild type and RS1-/- mice that were kept for 2 months on normal diet (ND), 
GGRD and high fat glucose rich diet (HFHGD). ND is normo-caloric and possesses high 
polysaccharide and low fat content while HFHGD is hyper-caloric and contains high 
monosaccharide and high fat content. The compositions and calorie contents of the three diets 
are shown in Table 1 and 2. After diet application, the mice were starved for 24 hours and the 
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phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG was 
measured in everted small intestinal segments taken from different parts of small intestine. 
These measurements were performed without pre-incubation of the everted small intestinal 
segments. The data were normalized to duodenal SGLT1 activity for AMG uptake in wild 
type and RS1-/- mice respectively. The mean ± standard error values in picomoles/cm/2 min 
used for normalization were: duodenum uptake in wild type mice fed with ND 370.7 ± 18.25 
and duodenum uptake in RS1-/- mice fed with ND 320 ± 19.36.  
The results are shown in Figure 10. Independent of diet in wild type and RS1-/- mice 
significant low activity was observed in ileum compared to duodenum and jejunum. In 
jejunum of wild type and RS1-/- mice, SGLT1 mediated uptake of 10 µM AMG in animals 
kept on hyper-caloric, fat rich diet (HFHGD and GGRD) were significantly reduced 
compared to animals kept on normo-caloric, low fat diet (ND). Since this effect was observed 
independent of the glucose or galactose content in diet, the effect might depend on the fat or 
total calorie content in diet. This fat dependent down-regulation was apparently also 
independent of RS1 as it was also observed in RS1-/- mice. In duodenum of wild type mice 
significant lower transport of SGLT1 was observed when mice were fed glucose-galactose 
reduced, fat rich diet (GGRD) compared to ND. This effect was absent in RS1-/- mice with 
different diet. Thus a glucose dependent long term regulation in duodenum was seen which 
was dependent on RS1.  
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Figure 10: Long term regulation of SGLT1 in small intestine to dietary glucose and fat 
content shows region specific RS1 dependence: Wild type and RS1-/- mice were fed with 
different diet for 2 months. They were starved for 24 hours prior to performing SGLT1 
dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer 
amount of [
14
C] AMG was measured for 2 minutes in everted segments of different small 
intestine regions in wild type (Fig 10 A) and RS1-/- (Fig 10 B) mice. Radioactivity of AMG 
uptake was calculated in terms of Picomoles/cm/2 min and normalized to respective mice 
normal diet (ND) duodenum. Ileum in wild type and RS1-/- mice significantly showed less 
SGLT1 activity in all diets (P<0.001) by ANOVA (*). Wild type and RS1-/- mice fed with 
high fat glucose rich diet (HFHGD) showed regional difference between jejunum and 
duodenum (P = 0.0169 & 0.0024 respectively) by 1 tailed paired t test (§). Jejunum region of 
ND in wild type and RS1-/- mice showed significant difference to mice fed with HFHGD 
with (P<0.05) by ANOVA, (*) and (P = 0.0009) by un-paired t test (!). Jejunum region of ND 
in wild type and RS1 -/- mice showed significant difference to mice fed with GGRD with 
(P<0.01) by ANOVA (*) and (P = 0.0004) by un-paired t test (!). RS1-/- mice did not show 
significant difference in SGLT1 activity between ND and diet with low glucose and galactose 
concentration (GGRD) in duodenum (P=0.1046) and ileum (P=0.1289) by un-paired t test.  
We also investigated whether the Km values of AMG uptake measured in BBMVs prepared 
from mice kept on ND, HFHGD and GGRD. The results indicated a borderline significant 
higher Km value for AMG in small intestine of RS1-/- mice that were kept on HFHGD which 
was not detected in wild type mice (Appendix VII). Since this observation may not reflect a 
relevant difference and was difficult to interpret it was not investigated further. 
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5. Discussion 
In this study, data was presented for a PKC dependent short term down-regulation of SGLT1 
function in the small intestine of mice which is independent of RS1. It is suggested that this 
effect may be due to PKC dependent phosphorylation of SGLT1. A second finding of this 
study is the observation that SGLT1 transport activity in jejunum is down-regulated 
independently of RS1 for long term adaptation to high fat containing diet. Thirdly it is 
observed that substrate transport by SGLT1 in duodenum is down-regulated in an RS1 
dependent manner after reduction in glucose and galactose content from the diet.  
I also obtained some data concerning the role of RS1 in SGLT1 regulation where absence of 
RS1 led to enhanced activity of SGLT1 (Figure 3). However this data showed relatively less 
enhanced effect in comparison to results previously demonstrated by other colleagues. 
Furthermore I also obtained some data concerning the role of RS1 in glucose dependent short 
term regulation of SGLT1 which contradicted the results obtained by colleagues in the 
laboratory, who used a different experimental approach. Dr. Helmut Kipp measured phlorizin 
inhibited AMG uptake in brush border membrane vesicles isolated from wild type mice small 
intestine after application of a 2.2 M glucose gavage in vivo or after incubation for 2 minutes 
of the small intestine with 20 mM AMG. He observed increased SGLT1 protein in the BBM 
and 2-4 times increase in SGLT1 mediated AMG uptake. In his experiments the RS1-/- mice 
was shown to already have an enhanced SGLT1 expression and no further increase in SGLT1 
activity or protein was observed with increased glucose luminal concentration. Performing 
AMG uptake measurements in everted small intestinal segments of small intestine after pre-
incubation in the absence or presence of 5 mM D-glucose I observed a relative small glucose 
dependent increase of AMG uptake in wild type mice as well as in RS1-/- suggesting an RS1 
independent short term up-regulation by glucose. These differences in results may be 
explained on the basis of the different methods employed for SGLT1 dependent uptake 
measurements.  Since Dr. Kipp detected that glucose dependent up-regulation in small 
intestine occurs very rapidly and could be observed after 2 minutes incubation period, it is 
probable that the up-regulation by 5 mM D-glucose in my experiments were reversed during 
the uptake measurements in the everted segments which were performed using an incubation 
period of 2 minutes. A second difficultly was that the transport activity of SGLT1 in small 
intestine was decreased during 1 hour pre-incubation period, which was employed to study 
the short term effects on SGLT1 regulation (Appendix I). Thus these different degrees of 
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inactivation during preincubation with and without glucose may have been determined in my 
experiments rather than the glucose dependent regulation. The inactivation by pre-incubation 
could have also altered the enhancement in SGLT1 activity of RS1-/- mice leading to the 
resultant small enhancement observed (Figure 3). Another reason for the differences in 
results could also be the difference in concentration of glucose applied for understanding its 
effect in short term regulation of SGLT1. Dr. Kipp employed a concentration of 20 mM and 
about 2 M to study the glucose dependent regulation of SGLT1. In my experiments I 
performed the study with only 5 mM D-glucose. Hence the decreased effect in the level of 
rise of SGLT1 activity for glucose dependent short term regulation may be dependent on the 
concentration of glucose along with the effect of inactivation during pre-incubation. Due to 
these limitations the further study to elucidate the effect of RS1 in short term regulation of 
SGLT1 were performed by employing the active motif QSP and its phosphorylation 
mimicking mutant QEP. QSP belongs to the N-terminal TGN-Reg domain of RS1 and 
mediate post-transcriptional down-regulation of SGLT1 (Vernaleken, Veyhl et al. 2007). 
Although QSP did mediate short term down-regulation of SGLT1, this down-regulation was 
independent of glucose and endogenous RS1 (Figure 5). This glucose independent down-
regulation of SGLT1 by QSP could be explained in terms of concentration. 15 mM 
concentration of QSP might be sufficient to inhibit the up-regulation of SGLT1 by 5 mM 
glucose. However the down-regulation of QSP to be effective in absence of glucose, which is 
a condition when endogenous RS1 is active, can be explained by different reasons. It could 
be stated that the SGLT1 activity is not completely down-regulated by endogenous RS1 and 
additive 15 mM QSP aids in further inhibition. Another possible explanation could be the 
experimental conditions. Mice were starved for 24 hours prior to uptake measurements. 
Starvation has been shown to lower affinity of SGLT1 and increase its uptake activity 
(Marciani, Lindi et al. 1987, Gupta and Waheed 1992, Gal-Garber, Mabjeesh et al. 2000). 
Hence the starvation of mice might have elevated SGLT1 activity that could have allowed 
QSP to mediate down-regulation on AMG transport even under a condition when endogenous 
RS1 is expected to be in an active state.  
The glucose dependent short term regulation of SGLT1 also involves increasing Km value for 
SGLT1 dependent AMG uptake (Figure 4). However RS1 did not affect the affinity for 
SGLT1 dependent AMG uptake (Figure 4). Hence it can be said that the glucose effect on 
SGLT1 affinity is independent of RS1. The SGLT1 affinity was also altered on PKC 
activation (Figure 9), where the Km value for SGLT1 mediated AMG transport is decreased 
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about 2 fold. In addition the PKC dependent short term regulation of SGLT1 occurred in an 
RS1 independent manner (Figure 7). But the observation of no additive down-regulation of 
SGLT1 when QEP was used with PKC activation (Figure 8) indicated that PKC and RS1 
might act independently within the same pathway to down-regulate SGLT1. RS1 is known to 
mediate short term regulation of SGLT1 post-transcriptionally by inhibiting the trafficking of 
vesicles containing SGLT1 to BBM (Veyhl, Keller et al. 2006). PKA and PKC are involved 
in regulating SGLT1 by altering exo-endocytosis of SGLT1 carrying vesicles to BBM 
(Wright, Hirsch et al. 1997). Protein kinases like PKA has also been reported to mediate short 
term regulation of SGLT1 by causing SGLT1 phosphorylation to change its affinity for 
substrate transport (Subramanian, Glitz et al. 2009). The SGLT1 sequence also has several 
putative phosphorylation sites for PKC (Hirsch, Loo et al. 1996). Hence the possible 
mechanism for PKC to mediate an increase in SGLT1 affinity and down-regulate SGLT1 
activity for glucose transport might involve the transporter phosphorylation that would affect 
post-transcriptionally SGLT1 turn over number and/or amount in the BBM. 
Based on the preliminary data which stated that RS1 is involved in the transcriptional 
regulation of SGLT1 for adaptation to glucose-galactose reduced diet (Filatova, Leyerer et al. 
2009) further data was obtained in this study to understand the dependence of RS1 in long 
term regulation of SGLT1 in small intestine for adaptation to diets different in glucose and fat 
content. The data obtained (Figure 10) showed the glucose dependent down-regulation of 
SGLT1 transport in duodenum of wild type mice for adaptation to glucose-galactose reduced 
diet (GGRD). The possible explanation for SGLT1 down regulation with low carbohydrate 
diet could be explained in terms of biosynthetic cost. In GGRD the cost of producing 
transporter might exceed the benefits of its activity. While on the other hand with high 
carbohydrate diet, energy synthesis would increase with increased absorption hence allowing 
increase in SGLT1 transporter activity (Ferraris and Diamond 1997). In support to this theory 
of biosynthetic cost, it was observed that the SGLT1 activity in wild type mice duodenum did 
not differ between polysaccharide rich (ND) or monosaccharide rich (HFHGD) diets. 
However this glucose dependent down-regulation of SGLT1 transport in duodenum was 
absent in RS1-/- mice. Hence the RS1 dependent long term down-regulation of SGLT1 for 
diet glucose adaptation was shown to be localized to duodenum region of small intestine. 
It was also observed that in the jejunum the SGLT1 activity was decreased in wild type and 
RS1-/- mice fed with fat rich diets (GGRD and HFHGD) when compared to the jejunual 
SGLT1 activity in mice fed with normal diet (ND) (Figure 10). This indicated a fat dependent 
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but RS1 independent long term down-regulation of SGLT1. Studies have reported increased 
SGLT1 gene expression in jejunum of mice fed with high carbohydrate/fat ratio when 
compared to low carbohydrate/fat diet (Honma, Mochizuki et al. 2009, Inoue, Mochizuki et 
al. 2011). Likewise this fat dependent down-regulation of SGLT1 activity could also be 
dependent on carbohydrate concentration. The HFHGD is a diet rich in simple sugars like 
monosaccharides and disaccharides. As complexity in carbohydrate availability is known to 
shift SGLT1 expression from jejunum to ileum due to slow digestion (Shimada, Mochizuki et 
al. 2009) these simple monosaccharides could have been easily absorbed in duodenum 
thereby leading to decreased SGLT1 function at jejunum. This effect would also account for 
the RS1 independent regional difference of SGLT1 activity between duodenum and jejunum 
region in mice fed with HFHGD. Likewise the decrease in jejunual SGLT1 activity for mice 
with GGRD could be due to the reduced amount of glucose and galactose in diet. Hence the 
RS1 independent down-regulation of SGLT1 in mice fed with HFHGD and GGRD could be 
a fat dependent and a glucose dependent effect. 
An RS1 independent and diet independent down-regulation of SGLT1 activity was observed 
in ileum. This could suggest that the age related long term regulation for prevalence of 
gradient distribution in SGLT1 transport from proximal to distal region in the small intestine 
(Toloza and Diamond 1990) is in-differed by dietary composition and RS1. 
In conclusion it can be stated that the RS1 dependence for SGLT1 regulation differs with 
respect to time scale of glucose exposure and is also specific to region in the small intestine. 
PKC activation was involved in the short term down-regulation of SGLT1 independent of 
RS1, but may follow the same path of RS1 for causing SGLT1 down-regulation. RS1 
mediated the long term down-regulation of SGLT1 specifically in duodenum region of small 
intestine in a manner dependent on glucose-galactose diet content. RS1 and diet independent 
long-term regulation of SGLT1 was observed to maintain posterior to distal gradient in 
SGLT1 function. An RS1 independent but dietary fat and/or glucose content dependent 
down-regulation of SGLT1 is present in mice jejunum region. 
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6. Appendix 
Appendix I: Tissue pre-incubation alters SGLT1 dependent substrate transport: 
In my study SGLT1 regulation was investigated by performing uptake measurement in 
everted small intestinal segments. These measurements allowed more direct control of the 
experimental conditions such as luminal glucose concentrations compared to in vivo gavage 
with D-glucose. The study of short term regulation of SGLT1 required pre-incubating the 
everted segments under required study condition for 1 hour. Pre-incubation of tissue might 
deprive tissue of energy source leading to decrease in SGLT1 efficiency for transport. In 
order to understand the effect of pre-incubation on SGLT1 activity phlorizin inhibited uptake 
of 10 µM AMG, labelled with tracer amount of [
14
C] AMG was measured in everted 
segments of wild type mice small intestine were compared without or with pre-incubation 
under 3 conditions – buffer (no energy resource), sodium pyruvate (energy resource) and 
glucose (substrate for SGLT1 and an energy resource). The result (Figure 11) showed no 
significant difference between buffer and sodium pyruvate pre-incubation. Pre-incubation 
with buffer and sodium pyruvate significantly decreased SGLT1 activity. However glucose 
showed significantly higher activity than pre-incubation with buffer or sodium pyruvate. 
 
Figure 11: Pre-incubation alters SGLT1 activity: Wild type mice were starved for 24hrs 
prior to perform SGLT1 dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, 
labelled with tracer amount of [
14
C] AMG was measured for 2 minutes in everted jejunum 
segments of wild type mice either without pre-incubation or after pre-incubating the segment 
in buffer, sodium pyruvate or glucose for 1hr. Radioactivity of AMG uptake was calculated 
in terms of Picomoles/cm/2min. Pre-incubation decreases SGLT1 activity in buffer (P<0.001) 
and sodium pyruvate (P<0.05), by ANOVA (*). 
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It can be discussed that though pre-incubation itself alters SGLT1 activity, the significant 
difference observed between pre-incubation condition of sodium pyruvate and glucose 
indicated substrate specific upregulation of SGLT1. Hence this method of pre-incubation was 
considered for the study of glucose dependent SGLT1 regulation despite the limitation in 
alteration of SGLT1 activity by pre-incubation. Furthermore the presence of the energy 
source sodium pyruvate failed to completely remove the pre-incubation effect on SGLT1 
activity. Hence pre-incubation in sodium pyruvate or buffer either could be used as control 
condition for glucose effect. 
Appendix II: Tissue pre-incubation does not alter SGLT1 affinity: 
Pre-incubation was shown to alter SGLT1 activity (Figure 11). Hence it was of interest 
whether pre-incubation altered SGLT1 affinity for transport. For this the Km values for AMG 
uptake were measured using BBMVs prepared from small intestines of RS1-/- mice without 
and with pre-incubation in sodium pyruvate for 1hr. Radioactive uptake measurements of 2 
seconds were made for different AMG concentrations (0.02 – 5 mM) in the presence and 
absence of 100 mM sodium and the Km values for sodium dependent uptake rates were 
calculated. The data represented in Figure 12 showed that pre-incubation does not alter 
SGLT1 affinity (P = 0.2036). 
 
Figure 12: Pre-incubation did not alter SGLT1 affinity: RS1-/- mice were starved for 24 
hours prior to BBMV preparation. BBMVs were prepared either with or without pre-
incubation in 9 mM sodium pyruvate for 1 hour. Sodium dependent affinity uptake 
measurements were performed for 2 sec in BBMVs incubated in Na
+
 containing buffer and 
K
+
 containing buffer at different radioactive AMG concentrations (0.02 mM – 5 mM). Figure 
12 represents the sodium-dependent uptake rates of individual experiments that were 
normalized to the respective Vmax values. Mean ± standard error values from independent 
experiments are shown. No significant difference was observed between Km values of 
BBMVs prepared without or with pre-incubation in sodium pyruvate, P = 0.2036, 1 sided un-
paired t test. 
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Appendix III: Segmental difference occurs within jejunum region of mice small 
intestine: 
Different segments within the jejunum region of the same mice were considered to perform 
paired comparisons under different study conditions. However for these comparisons it was 
necessary to understand the difference within these segments to calculate the actual effect of 
the desired study condition. Hence phlorizin inhibited uptake of 10 µM AMG, labelled with 
tracer amount of [
14
C] AMG was measured within different sections of the mice jejunum 
region. To overcome the difference within day to day analysis the average of segment 1 
within the jejunum region was used to normalize the measurements. The mean ± standard 
error values in picomoles/cm/2min used for normalization were: wild type mice pre-
incubation without glucose 163.5 ± 19.84, RS1-/- mice pre-incubation without glucose 178.3 
± 17.88, wild type mice pre-incubation with glucose 337.9 ± 29.77, RS1-/- mice pre-
incubation with glucose 315.2 ± 8.718. The data indicated a border line significant glucose 
dependent up-regulation in wild type (P = 0.1843) and RS1-/- mice (P = 0.0728). The result 
(Figure 13) showed the segmental difference observed in the jejunum region of wild type and 
RS1-/- mice under conditions of pre-incubation in buffer or glucose.   
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Figure 13: Jejunal region of small intestine shows segmental difference in AMG uptake 
activity: Wild type and RS1-/- mice were starved for 24hrs prior to perform SGLT1 
dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer 
amount of [
14
C] AMG was measured for 2 minutes in everted jejunum segments of wild type 
(Figure 13 A and B) and RS1-/- (Figure 13 C and D) mice after pre-incubation in buffer 
(Figure 13 A and C) or glucose (Figure 13 B and D). Radioactivity of AMG uptake was 
calculated in terms of Picomoles/cm/2min.  The values were normalized to the first segment 
of wild type or RS1-/- mice jejunum in buffer or glucose condition respectively. Differences 
were analysed by ANOVA (*) or 1 sided paired t test (§) between 4 different segments of 
jejunum region within the mice small intestine.  Significant segmental difference was 
observed in the region of jejunum in mice small intestine.  
The values obtained in the above results for the different segments of jejunum region were 
used to normalize the respective segment in any study performed.   
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Appendix IV: Brefeldin A activity is dependent on glucose and RS1: 
Brefeldin A is an exocytotic inhibitor. Since post-transcriptional short term regulation of 
SGLT1 can be mediated by vesicular trafficking of SGLT1 carrying vesicles, the role of 
Brefeldin A was investigated for short term regulation of SGLT1. For this, phlorizin inhibited 
uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG was measured in wild type 
and RS1-/- mice small intestine everted segments after pre-incubation in buffer or glucose 
with or without Brefeldin A (12µM). The measurements were normalized to uptake after pre-
incubation in buffer (Figure 14A and 14B) or glucose (Figure 14C and 14D) condition of 
wild type (Figure 14A and 14C) and RS1-/- (Figure 14B and 14D) mice respectively. The 
measurements were normalized to uptake after pre-incubation of small intestine everted 
segments of wild type mice or RS1-/- mice in buffer (Figure 5A and 5B) or D-glucose 
(Figure 5C and 5D).  The mean ± standard error  values in picomoles/cm/2min used for 
normalization were: wild type mice pre-incubation without glucose 120.6 ± 11.17, RS1-/- 
mice pre-incubation without glucose 144.3 ± 21.42, wild type mice pre-incubation with 
glucose 258.7 ± 17.32, RS1-/- mice pre-incubation with glucose 227.2 ± 13.89. The results 
showed a borderline significant downregulation of SGLT1 dependent AMG uptake in wild 
type and RS1-/- mice on pre-incubation with Brefeldin A in buffer. However in glucose, pre-
incubation with Brefeldin A mediated only a borderline significant down regulation in wild 
type mice. 
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Figure 14: Brefeldin A inhibits exocytotic inhibition of SGLT1 vesicular trafficking in a 
complex manner: Wild type and RS1-/- mice were starved for 24hrs prior to perform 
SGLT1 dependent AMG uptake. Phlorizin inhibited uptake of 10 µM AMG, labelled with 
tracer amount of [
14
C] AMG was measured for 2 minutes in everted jejunum segments of 
wild type mice (Fig 14A and C) and RS1-/- mice (Fig 14B and D) after pre-incubating the 
segment in buffer (Figure 14A and B) or glucose (Figure 14C and D) with or without 7-
12µM Brefeldin A for 1hr. Radioactivity of AMG uptake was calculated in terms of 
Picomoles/cm/2min and normalized to respective mice buffer or glucose control. Buffer pre-
incubated with Brefeldin A inhibited SGLT1activity in wild type mice (P = 0.0472) and in 
RS1 -/- mice (P = 0.0440) tested by 1sided paired test (§). However Brefeldin A inhibited 
SGLT1 activity only in wild type mice when incubated in glucose (P = 0.0440) (§). 
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The difference in the inhibition by Brefeldin A between wild type and RS1-/- under glucose 
condition indicated a complex mechanism. SGLT1 regulation mediated by Brefeldin A might 
be dependent on intracellular glucose concentration and endogenous RS1. 
Appendix V: QEP down regulates SGLT1 activity by exocytotic inhibition of SGLT 
carrying vesicles: 
QCP a functional tripeptide within the RS1 sequence down-regulates SGLT1 without adding 
to the exocytotic inhibition of SGLT1 vesicular trafficking by Brefeldin A in the Xenopus 
laevis oocyte system (Vernaleken, Veyhl et al. 2007). QSP is another functional tripeptide of 
RS1 sequence. For understanding the mechanism of SGLT1 regulation by QSP, its 
phosphorylation mimicking mutant QEP effect on SGLT1 activity was compared to 
inhibitory effect of Brefeldin A. As Brefeldin A did not mediate inhibition in RS1-/- mice 
when glucose was present (Figure 15 D), phlorizin inhibited uptake of 10 µM AMG, labelled 
with tracer amount of [
14
C] AMG was measured in everted segments of wild type mice alone 
after pre-incubation in glucose with Brefeldin A (12 µM), QEP (15 mM) or Brefeldin A with 
QEP. The uptake measurements were normalized to the mean ± standard error value 293.9 ± 
11.36 in picomoles/cm/2 min obtained for the everted segments of wild type mice small 
intestine after pre-incubation with glucose. The data in figure 15 showed no additive down-
regulation of SGLT1 activity by QEP to the exocytotic inhibition of SGLT1 vesicles by 
Brefeldin A. This possibly indicated that QEP mediated down-regulation of SGLT1 by 
inhibiting the trafficking of SGLT1 carrying vesicles to the apical surface.  
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Figure 15: Brefeldin A and QEP inhibit exocytosis of SGLT1 carrying vesicles: Wild 
type mice were starved for 24 hours prior to perform SGLT1 dependent AMG uptake. 
Phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG was 
measured for 2 minutes in everted jejunum segments of wild type mice after pre-incubating 
the segment in glucose with or without QEP, Brefeldin A and QEP with Brefeldin A for 1hr. 
Radioactivity of AMG uptake was calculated in terms of Picomoles/cm/2min and normalized 
to wild type mice glucose control. No additive down-regulation of SGLT1 function was 
observed by QEP with Brefeldin A over the inhibition by QEP or Brefeldin A alone. 
Appendix VI: PKC down regulates SGLT1 activity by aiding to exocytotic inhibition of 
SGLT1 vesicles:  
QEP and Brefeldin A do not additively down-regulate SGLT1 activity (Figure 15). RS1 
regulates SGLT1 in a PKC dependent manner (Veyhl, Wagner et al. 2003). PKC down-
regulated SGLT1 activity independent of RS1 (Figure 7) however the PKC dependent down-
regulation of SGLT1 was suggested to act by the same pathway of RS1 mediated down-
regulation of SGLT1 (Figure 8). Since RS1 mediated down-regulation of SGLT1 by 
inhibiting its exocytotic trafficking to plasma membrane (Appendix V) the involvement of 
PKC activation was investigated for the exocytotic inhibition of SGLT1 vesicles. For this, 
phlorizin inhibited uptake of 10 µM AMG, labelled with tracer amount of [
14
C] AMG was 
measured in wild type mice jejunum everted segments after pre-incubation in 5 mM D-
glucose with PMA (5 µM), Brefeldin A (12 µM) or PMA with Brefeldin A. The uptake 
measurements were normalized to the mean ± standard error value 293.9 ± 11.36 in 
picomoles/cm/2 min obtained for the everted segments of wild type mice small intestine after 
pre-incubation with glucose. Results (Figure 16) showed an additive PKC mediated down 
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regulation on SGLT1 activity to Brefeldin A inhibition. This data suggested that PKC and 
Brefeldin A alone might mediate only partial exocytotic inhibition of SGLT1 carrying 
vesicles and when together complete the down-regulation of SGLT1 or PKC and Brefeldin A 
inhibited SGLT1 by different pathways.  
 
Figure 16: Brefeldin A and PKC inhibit SGLT1 additively: Wild type mice were starved 
for 24hrs prior to perform SGLT1 dependent AMG uptake. Phlorizin inhibited uptake of 10 
µM AMG, labelled with tracer amount of [
14
C] AMG was measured for 2 minutes in everted 
jejunum segments of wild type mice after pre-incubating the segment in glucose with or 
without PMA, Brefeldin A and PMA with Brefeldin A for 1hr. Radioactivity of AMG uptake 
was calculated in terms of Picomoles/cm/2min and normalized to wild type mice glucose 
control. PMA with Brefeldin A inhibition were additive to PMA (P<0.05) and Brefeldin A 
(P=0.015) inhibition alone by one sided un-paired, t test (!).  
Appendix VII: SGLT1 affinity for substrate transport during diet adaptation might be 
RS1 dependent: 
To understand whether adaptation to different diet modulates SGLT1 substrate affinity and to 
explore the involvement of RS1 in this regulation, Km values for sodium dependent AMG 
uptake rates were calculated. The radioactive uptake measurements of 2 seconds were made 
for different AMG concentrations (0.02 – 5 mM) in the presence and absence of 100 mM 
sodium in BBMVs isolated from small intestine of wild type and RS1-/- mice kept for 2 
months with different diets.  The radioactivity measured was calculated in Picomoles/mg/2 
seconds and the values were plotted using Michaelis-Menten equation in a nonlinear 
regression curve to obtain Km values. Comparing the Km values the results (Figure 17) 
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showed that diet does not alter affinity in wild type mice. However RS1-/- mice fed with 
HFHGD (Km value 2.232 ± 0.471 mM) showed a borderline significance for difference in Km 
value when compared with mice fed with ND (Km value 0.8717 ± 0.197) and GGRD (Km 
value 0.8290 ± 0.0315 mM).  
 
Figure 17: RS1 might alter SGLT1 substrate affinity for diet adaptation: Mice were fed 
with different diets for 2 months and starved for 24 hours prior to preparing BBMVs from 
mice small intestine. Sodium dependent uptake measurements were performed for 2 seconds 
in BBMVs incubated in Na
+
 containing buffer and K
+
 containing buffer at different 
radioactive AMG concentrations (0.02 mM – 5 mM). Radioactivity was measured in terms of 
Picomoles/mg/2 seconds and plotted to fit in non-linear regression curve using Michaelis –
Menten equation to determine Km value. Significant difference was observed between Km 
value of RS1-/- mice fed with HFHGD to mice fed with ND (P=0.0395) and GGRD (P = 
0.0339) by1 sided un-paired t test (!). 
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7. Summary: 
The Na
+
-D-glucose cotransporter in small intestine is regulated in response to food 
composition. Short term regulation of SGLT1 occurs post-transcriptionally in response to 
changes in luminal glucose. Adaptation to dietary carbohydrate involves long term regulation 
at the transcriptional level. The intracellular protein RS1 (gene RSC1A1) is involved in 
transcriptional and post-transcriptional regulation of SGLT1. RS1 contains an N-terminal 
domain with many putative phosphorylation sites. By Expressing SGLT1 in oocytes of 
Xenopus laevis it was previously demonstrated that the post-transcriptional down-regulation 
of SGLT1 by RS1 was dependent on the intracellular glucose concentration and activated by 
protein kinase C (PKC). The role of RS1 for short term regulation of SGLT1 in mouse small 
intestine in response to glucose and PKC was investigated comparing effects in RS1-/- mice 
and wildtype mice. Effects on SGLT1 activity were determined by measuring phlorizin 
inhibited uptake of α-methylglucoside (AMG). The involvement of RS1 in glucose dependent 
short term regulation could not be elucidated for technical reasons. However, evidence for 
RS1 independent short-term downregulation of SGLT1 after stimulation of PKC could be 
provided. It was shown that this downregulation includes decrease in the amount and/or in 
turnover of SGLT1 in the brush-border membrane as well as an increase of substrate affinity 
for AMG transport. Trying to elucidate the role of RS1 in long term regulation of SGLT1 in 
small intestine in response to glucose and fat content of the diet, wildtype and RS1-/- mice 
were kept for 2 months on a normo-caloric standard diet with high glucose and low fat 
content (ND), on a hyper-caloric glucose-galactose reduced diet with high fat content 
(GGRD) or on a hyper-caloric diet with a high fat and high glucose content (HFHGD). 
Thereafter the animals were starved overnight and SGLT1 mediated AMG uptake was 
measured. Independent of diet AMG uptake in ileum was smaller compared to duodenum and 
jejunum. In jejunum of wildtype and RS1-/- mice kept on the fat rich diets (GGRD and 
HFHGH) transport activity of SGLT1 was lower compared to mice kept on ND with low fat 
content. This result suggests an RS1 independent downregulation due to fat content of diet. 
Different to RS1-/- mice, the duodenum of wildtype mice showed transport activity of 
SGLT1 smaller in mice kept on glucose galactose reduced diet (GGRD) compared to the 
glucose galactose rich diets (ND and HFHGG). These data indicate that RS1 is involved in 
glucose dependent long term regulation in duodenum. 
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8. Zusammenfassung: 
Der Na
+
-Glukose-Cotransporter SGLT1 im Dünndarm wird in Abhängigkeit zur 
Nahrungszusammensetzung reguliert. Kurzzeitregulation von SGLT1 tritt posttranskritionell 
als Antwort zu sich ändernden Glukosekonzentrationen im Darmlumen auf. Anpassung an 
Nahrungskohlenhydrate beinhaltet die Langzeitregulation auf transkripionellem Level. Das 
intrazelluläre Protein RS1 (Gen RSC1A1) ist an der transkriptionellen und post-
transkriptionellen Regulation von SGLT1 beteiligt. Es enthält eine N-terminale Domäne mit 
vielen putativen Phosphorylierungsstellen. Bei der Expression von SGLT1 im Xenopus leavis 
Oocytensystem wurde gezeigt, dass die posttranskriptionelle Herunterregulation von SGLT1 
durch RS1 von der intrazelluläre Glukosekonzentration abhängt und durch Proteinkinase C 
(PKC) aktiviert wird. Die Rolle von RS1 in der Kurzzeitregulation von SGLT1 im Dünndarm 
der Maus als Antwort auf Glukose und PKC wurde durch vergleichende Studien zwischen 
RS1- knockout (RS1-/-)- Mäusen und Wildtyp-Mäusen untersucht. Effekte auf die SGLT1-
Aktivität wurden durch Messung der durch Phlorizin inhibierbaren Aufnahme des SGLT1-
spezifischen Substrats α-Methyl-Glycopyranosid (AMG) bestimmt. Der Einfluss von RS1 in 
der Glukose-abhängigen Kurzzeitregulation konnte aus technischen Gründen nicht untersucht 
werden, jedoch gab es Anzeichen für eine von RS1 unabhängige Kurzzeitregulation von 
SGLT1 durch PKC. Es wurde gezeigt, dass diese Herunterregulation sowohl eine Abnahme 
der Menge und/oder der Umsatzrate von SGLT1 in der Bürstensaummembran wie auch eine 
Zunahme der Substrat-Affinität für den AMG-Transport beinhaltet. Um die Rolle von RS1 
auf die Langzeitregulation von SGLT1 in Dünndarm als Antwort auf den Glukose- und 
Fettgehalt der Nahrung zu untersuchen, wurden Wildtyp- und RS1-/- Mäuse für 2 Monate 
entweder auf einer normalenergetischen Standarddiät mit hohem Glukose- und niedrigem 
Fettgehalt (ND), auf einer hochenergetischen Diät mit reduziertem Glukose und Galaktose-
Gehalt (GGRD) oder auf einer hochenergetischen Diät mit hohem Fett- und Glukosegehalt 
(HFHGD) gehalten. Danach wurden die Tiere über Nacht gefastet und die durch SGLT1 
vermittelte AMG –Aufnahme gemessen. Unabhängig der Diät war die AMG-Aufnahme im 
Ileum geringer als in Duodenum und Jejunum. Im Jejunum von Wildtyp- und RS1-/- Mäusen 
die auf einer fettreichen Diät (GGRD und HFHGD) gehalten wurden war die 
Transportaktivität von SGLT1 geringer verglichen mit der Aktivität von Mäusen auf ND. 
Dieses Ergebnis lässt eine RS1-unabhängige Herunterregulation die durch den Fettgehalt 
hervorgerufen wird vermuten. Anders als in RS1-/- Mäusen war die Transportaktivität von 
SGLT1 im Duodenum von Wildtypmäusen bei der Glukose-Galaktose- reduzierten Diät 
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niedriger verglichen mit den Glukose-Galaktose-reichen Diäten (ND und HFHGD). Diese 
Daten legend die Vermutung nahen, das RS1 an der Glukose-abhängigen Langzeitregulation 
im Duodenum beteiligt ist.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations 
 
50 
 
9. Abbreviations: 
AM  Adrenomedullin 
AMG  Alpha Methyl D-Glucopyranoside 
AMPK  5’ – Adenosine Mono phosphate activated protein kinase 
BBMV Brush border membrane vesicles 
cRNA  Complementary Ribonucleic acid 
cAMP  cyclic Adenosine Mono phosphate 
cPLA2  cytosolic Phospholipase A2 
CCK  Cholecystokinin 
ERK  Extracellular signal regulated kinase 
EGF  Epidermal growth factor 
GGRD  Glucose-galactose reduced diet 
GLP-2  Glucagon like peptide-2 
GLUT  Facilitated glucose transporters 
GSK3β Glycogen Synthase kinase 3 beta 
HFHGD High fat high glucose diet 
HNF1 α  Hepatocyte nuclear factor 1 alpha 
HNF1 β Hepatocyte nuclear factor 1 beta 
IL-6  Interleukin 6 
JNK  Jun – N – Terminal kinase 
LLCPK1 Porcine kidney epithelial cell line 
mTOR  Mammalian target of rapamycin  
MAPK  Mitogen activated protein kinase 
ND  Normal diet / high polysaccharide diet /Standard control diet 
NF-κB  Nuclear factor kappa light chain enhancer of activated B cells 
p38 MAPK p38 Mitogen activated protein kinase 
PAMP  Proadrenomedullin N – terminal 20 peptide 
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PI3K  Phosphotidylinositol 3 Kinase 
PIP5K3 Phosphotidylinositol 3 phosphate 5 kinase  
PI3,5P2 Phosphotidylinositol 3,5 biphophate 
PKA  Protein Kinase A 
PKB  Protein Kinase B/ Akt 
PKC  Protein Kinase C 
PMA  Phorbol – 12 – Myristate – 13 – Acetate 
PME n  Plasma membrane enriched  
PTCs  Renal proximal tubule cells 
QEP  Gln-Glu-Pro 
QSP  Gln-Ser-Pro 
RAS  renin – angiotensin system  
RNS  21 residue long nuclear shuttling domain 
RELMβ Resistin like molecule β 
SMIT  SGLT1 homologous Na
+
 myoinositol co-transporter  
SEM  Standard Error of Mean ± standard error  
SLC5A Solute carrier family  
SGK-1  Serum and Gluco-corticoid inducible kinase 
SGLT1  Sodium dependent glucose transporter – 1 
TGN  Trans Golgi Network 
TGN-Reg Post-transcriptional regulatory domain of RS1 
TTK2  Tau tubulin kinase 2 
OCT1  Organic Cation transporter 1 
OCT2  Organic Cation transporter 2 
UBA  Ubiquitin associated domain 
URE  Uridine rich sequence 
UTR  3’ Un-translated Region 
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Vmax  Maximum velocity of transport 
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